Fil LTD Vertex Pharmaceuticals Inc Transaction History

Fil LTD

$103 Billion
Q3 2024

A detailed history of Fil LTD transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Fil LTD holds 7,031 shares of VRTX stock, worth $3.17 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

7,031

Previous 7,705 8.75%

Holding current value

$3.17 Million

Previous $3.61 Million 9.47%

% of portfolio

0.0%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$460.0 - $505.78 $310,040 - $340,895	-674 Reduced 8.75%	7,031 $3.27 Million
Q2 2024 Aug 13, 2024	BUY	$392.81 - $485.53 $2.76 Million - $3.41 Million	7,020 Added 1024.82%	7,705 $3.61 Million
Q1 2024 May 13, 2024	BUY	$407.69 - $446.08 $1,223 - $1,338	3 Added 0.44%	685 $286,000
Q4 2023 Feb 13, 2024	BUY	$343.0 - $410.68 $233,926 - $280,083	682 New	682 $277,000
Q2 2023 Aug 11, 2023	SELL	$314.42 - $351.91 $283,292 - $317,070	-901 Reduced 1.88%	47,037 $16.6 Million
Q1 2023 May 11, 2023	SELL	$283.23 - $323.1 $47.5 Million - $54.2 Million	-167,736 Reduced 77.77%	47,938 $15.1 Million
Q4 2022 Feb 13, 2023	SELL	$285.76 - $321.48 $9.72 Million - $10.9 Million	-34,019 Reduced 13.62%	215,674 $62.3 Million
Q3 2022 Nov 10, 2022	BUY	$273.83 - $305.53 $585,996 - $653,834	2,140 Added 0.86%	249,693 $72.3 Million
Q2 2022 Aug 12, 2022	BUY	$234.96 - $292.55 $24.8 Million - $30.9 Million	105,668 Added 74.47%	247,553 $69.8 Million
Q1 2022 May 13, 2022	BUY	$221.42 - $260.97 $30.4 Million - $35.8 Million	137,222 Added 2942.78%	141,885 $37 Million
Q4 2021 Feb 14, 2022	BUY	$177.01 - $223.45 $699,543 - $883,074	3,952 Added 555.84%	4,663 $1.02 Million
Q3 2021 Nov 15, 2021	SELL	$181.39 - $202.99 $20.7 Million - $23.2 Million	-114,250 Reduced 99.38%	711 $129,000
Q2 2021 Aug 13, 2021	SELL	$187.49 - $221.1 $9.17 Million - $10.8 Million	-48,928 Reduced 29.85%	114,961 $23.2 Million
Q1 2021 May 14, 2021	BUY	$207.02 - $241.31 $33.9 Million - $39.5 Million	163,804 Added 192710.59%	163,889 $35.2 Million
Q4 2020 Feb 08, 2021	SELL	$207.01 - $276.09 $18.3 Million - $24.4 Million	-88,400 Reduced 99.9%	85 $20,000
Q3 2020 Nov 13, 2020	SELL	$255.65 - $303.1 $13.4 Million - $15.9 Million	-52,485 Reduced 37.23%	88,485 $24.1 Million
Q2 2020 Aug 13, 2020	SELL	$225.48 - $295.8 $21.9 Million - $28.7 Million	-97,141 Reduced 40.8%	140,970 $40.9 Million
Q1 2020 May 14, 2020	BUY	$199.77 - $247.81 $38.8 Million - $48.2 Million	194,406 Added 444.81%	238,111 $56.7 Million
Q4 2019 Feb 07, 2020	BUY	$166.71 - $223.91 $7.29 Million - $9.78 Million	43,699 Added 728316.69%	43,705 $9.57 Million
Q3 2019 Nov 13, 2019	BUY	$166.23 - $187.09 $166 - $187	1 Added 20.0%	6 $1,000
Q2 2019 Aug 13, 2019	SELL	$164.61 - $190.37 $164 - $190	-1 Reduced 16.67%	5 $1,000
Q1 2019 May 13, 2019	BUY	$163.73 - $194.7 $163 - $194	1 Added 20.0%	6 $1,000
Q3 2018 Nov 09, 2018	BUY	$167.73 - $192.74 $838 - $963	5 New	5 $1,000
Q3 2017 Nov 13, 2017	SELL	$148.13 - $162.24 $24.2 Million - $26.5 Million	-163,316 Closed	0 $0
Q2 2017 Aug 29, 2017	BUY	N/A	163,316	163,316 $21 Million

Others Institutions Holding VRTX

# of Institutions

1,723

Shares Held

222M

Call Options Held

1.58M

Put Options Held

1.36M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $116B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fil LTD, based on Form 13F filings with the SEC.

News

Stay updated on Fil LTD with notifications on news.

Account